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S-N-6
EFFECTS OF ESTROGEN ON CATECHOL-O-METHYLTRANSFERASE (COMT)
Jiang Hong , Feng Zhe-huif, David Ramsdenf, Ho Shu-Leongf Division of Neurology, University Dept of
Medicine, Queen Mary Hospital, The University of Hong Kong, and Dept of Medicine, University of
Birnimgham$, UK
COMT is a crucial enzyme in dopamine and levodopa metabolism. COMT inhibitors are effective adjunct
therapy to Ldopa in Parkinson's Disease (PD). We have previously shown that 17(3-estradiol can downregulate
human COMT gene transcription via its promoter regions using CAT reporter activity assays. Purified antiserum
containing human COMT antibodies developed using specifically designed oligopeptides injected into sheep,
was used to carry out Western Blots. We showed that COMT protein expression was decreased in a dose-
dependent manner in MCF-7 cells after exposure to physiologic concentrations of 17p-estradiol for 72 hours.
A specific estrogen receptor antagonist (ICI 182780) blocked this estrogenic effect. Using a radioenzymatic
assay, we further showed that COMT activity was similarly affected. We investigated the underlying mechanism
of these estrogenic effects by characterizing the function of estrogen response elements (EREs) in the proximal
promoter region by exploring their DNA-protein binding activities. Our gelshift assays showed that nuclear
proteins from MCF-7 cells could specifically bind to our ERE1 or ERE2 probe. Preincubation of the nuclear
protein with excess non-labeled probes or estrogen receptor (a and p) antibodies competitively inhibited this
binding. Using semiquantitative gelshifts, we also showed that 17p-estradiol can increase estrogen receptor
(ER)-ERE binding activity in a dose-dependent manner. We conclude that 17p-estradiol can decrease COMT
protein expression and activity in a dose-dependent manner through estrogen receptors. These estrogenic
effects were associated with a dose-dependent increase in ER-ERE binding. Our results can explain the
worsening of motor control during menstruation in premenopausal PD patients, and after withdrawal of hormone
replacement therapy in postmenopausal PD patients. It also suggests that estrogen can be a useful adjunct
therapy for PD in postmenopausal women.
S-RC-1
NITRIC OXIDE (NO) LEVELS IN EXHALED AIR, SPUTUM, SERUM, SALIVA AND URINE OF
BRONCHIECTASIS SUBJECTS: A COMPARISON STUDY
KWT Tsang. S Chan, P Fung, L Zheng, IHY Shum, R Leung, JCM Ho, S Ip, J Wang, WK Lam. University
Dept of Medicine, The University of Hong Kong, Hong Kong SAR.
Endogenous NO has received tremendous attention in the last few years and promises to be a final common
path for the pathogenesis of many respiratory, renal, neurological and liver diseases. Exhaled NO is increased
in asthma but decreased in cystic fibrosis, cigarette smoking and HIV infection. However, the levels of NO in
other body fluids including saliva, urine and serum have not been evaluated and compared with exhaled NO.
We have, therefore, determined their correlation in a cohort of xx patients with stable bronchiectasis (xxF;
mean age±SD 58.2± 14.lyrs; FEV, 72.5±28.9% pred; and FVC 81.5±23.3% pred). Exhaled NO was measured
by using a Sievers NO Analyser280 at a steady exhaled pressure of 20 torr with chemiluminescence. Body
fluids NO contents were analyzed by measuring the total nitrate products, after de-proteinisation, using the
same package. There were significant differences (p<0.05) between the exhaled NO (25.5±21.8 units) levels
compared with the simultaneous levels in serum (127.4±94.3), sputum sol (1167.6± 1400), urine
(2559.6+4083.4), and saliva (3085.9± 3839.7). There no correlation between exhaled NO levels with those in
the aforementioned bodily fluids. However, there was a positive correlation between the levels of NO between
serum and sputum (r=0.51, p=0.0001), urine (0.56, 0.0001), and saliva (0.48, 0.0001). There was also a
weaker correlation between the level of NO in sputum and urine (0.35, 0.003). Our results show, for the first
time, the relationship between simultaneous levels of NO in exhaled air and other bodily fluids and should help
researchers in future studies. (Supported by a CRCG Grant of the University of Hong Kong)
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